UNITED STATES
	SECURITIES AND EXCHANGE COMMISSION
	Washington, D.C. 20549
	FORM 8-K
	CURRENT REPORT
	Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
	Date of Report (Date of earliest event reported): June 8, 2010
	ONCOGENEX PHARMACEUTICALS, INC.
	(Exact name of registrant as specified in its charter)
|  |  |  |  |  | 
| Delaware |  | 033-80623 |  | 95-4343413 | 
|  |  |  |  |  | 
| (State or other jurisdiction of incorporation)
 |  | (Commission File Number) |  | (IRS Employer Identification No.) | 
 
|  |  |  | 
| 1522 217th Place S.E. Bothell, Washington
 |  | 98021
 | 
|  |  |  | 
| (Address of principal executive offices) |  | (Zip Code) | 
 
	Registrants telephone number, including area code:
	(425) 686-1500
	(Former name or former address, if changed since last report.)
	Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| o |  | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | 
|  | 
| o |  | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | 
|  | 
| o |  | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | 
|  | 
| o |  | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | 
 
	 
	 
 
	 
	 
	Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
	Officers; Compensatory Arrangements of Certain Officers.
	At the 2010 Annual Meeting of Stockholders (the 2010 Annual Meeting) of OncoGenex
	Pharmaceuticals, Inc. (the Company) held on June 8, 2010, stockholders of the Company approved
	the 2010 Performance Incentive Plan (the 2010 Plan). A summary of the material terms of the 2010
	Plan is set forth in the Companys definitive proxy statement filed with the Securities and
	Exchange Commission on April 19, 2010 (the Proxy Statement) and is incorporated by reference
	herein. Such summary is qualified in its entirety by reference to the full text of the 2010 Plan,
	which is filed as Appendix A to the Proxy Statement. The related form of stock option agreement
	and form of restricted stock purchase agreement are filed herewith as Exhibits 10.1 and 10.2,
	respectively.
	Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
	Effective June 8, 2010, the Board of Directors of the Company (the Board) amended and
	restated the Companys bylaws to (i) clarify that consents and other director communications may be
	made by electronic transmission, (ii) remove the seven (7) person limitation on the size of the
	Board, (iii) remove reference to the second Tuesday in May as the default date for annual meetings
	of stockholders, (iv) revise the methods and timing requirements regarding the giving of notice for
	Board meetings and (v) make various technical and typographical changes. A copy of the amended and
	restated bylaws of the Company is filed herewith as Exhibit 3.1.
	Item 5.05 Amendments to the Registrants Code of Ethics, or Waiver of a Provision of the Code of
	Ethics.
	On June 8, 2010, the Board approved revisions to the Companys whistle blowing policy, which
	is incorporated into the Companys Code of Business Conduct and Ethics and which outlines the
	principles and commitments that the Company has made with respect to the treatment of reports by
	personnel. The revisions were made to clarify the roles and responsibilities for handling reports,
	to add a provision for a third party service provider to whom anonymous reports may be submitted
	and to make various technical and typographical changes. A copy of the whistle blowing policy is
	available on the Companys website at www.oncogenex.com.
	Item 5.07 Submission of Matters to a Vote of Security Holders.
	On June 8, 2010, the Company held its 2010 Annual Meeting at which (i) the six nominees
	identified in the table below were elected to the Companys Board to serve until the Companys 2011
	Annual Meeting of shareholders or until successors are duly elected and qualified, (ii) the
	appointment of Ernst & Young LLP as the Companys independent auditor for the current fiscal year
	was ratified (the Auditor Ratification), (iii) the 2010 Plan was approved and (iv) the amendment
	to the Companys certificate of incorporation to increase the number of authorized shares of common
	stock of the Company to 25,000,000 (a copy of which is filed herewith as Exhibit 3.2 (the
	Certificate of Amendment)) was approved. The matters acted upon at the 2010 Annual Meeting are
	described in more detail in the Proxy Statement. Set forth below are the final voting tallies for
	the 2010 Annual Meeting:
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Proposal: Election of Directors |  | For |  |  | Withheld |  |  | Broker Non-Vote |  | 
| 
	Scott Cormack
 |  |  | 2,997,878 |  |  |  | 65,997 |  |  |  | 1,469,760 |  | 
| 
	Michelle Burris
 |  |  | 2,998,014 |  |  |  | 65,861 |  |  |  | 1,469,760 |  | 
| 
	Neil Clendeninn
 |  |  | 2,998,053 |  |  |  | 65,822 |  |  |  | 1,469,760 |  | 
| 
	Jack Goldstein
 |  |  | 2,997,270 |  |  |  | 66,605 |  |  |  | 1,469,760 |  | 
| 
	Martin Mattingly
 |  |  | 2,997,463 |  |  |  | 66,412 |  |  |  | 1,469,760 |  | 
| 
	Stewart Parker
 |  |  | 2,997,528 |  |  |  | 66,347 |  |  |  | 1,469,760 |  | 
 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Proposal: |  | For |  |  | Against |  |  | Abstain |  |  | Broker Non-Vote |  | 
| 
	Auditor Ratification
 |  |  | 4,477,459 |  |  |  | 46,800 |  |  |  | 9,376 |  |  |  | 0 |  | 
| 
	2010 Plan
 |  |  | 2,927,749 |  |  |  | 122,136 |  |  |  | 13,990 |  |  |  | 1,469,760 |  | 
| 
	Certificate of Amendment
 |  |  | 3,410,682 |  |  |  | 1,053,391 |  |  |  | 1,062,659 |  |  |  | 0 |  | 
 
	 
	2
 
	 
	Item 8.01 Other Events.
	On June 8, 2010, the Board approved non-material revisions to the Companys Short Term
	Incentive Awards Program (the STIP). The STIP, as revised, is filed herewith as Exhibit 10.3.
	Item 9.01 Financial Statements and Exhibits.
	(d) Exhibits
|  |  |  |  |  | 
| Exhibit No. |  | Description | 
|  |  |  |  | 
	 
 | 
|  | 3.1 |  |  | 
	Fourth Amended and Restated Bylaws of OncoGenex Pharmaceuticals, Inc.
 | 
|  |  |  |  | 
	 
 | 
|  | 3.2 |  |  | 
	Certificate of Amendment of Certificate of Incorporation of OncoGenex Pharmaceuticals, Inc.
 | 
|  |  |  |  | 
	 
 | 
|  | 10.1 |  |  | 
	Form of OncoGenex Pharmaceuticals, Inc. 2010 Stock Option Agreement under the 2010 Performance
	Incentive Plan
 | 
|  |  |  |  | 
	 
 | 
|  | 10.2 |  |  | 
	Form of OncoGenex Pharmaceuticals, Inc. 2010 Restricted Stock Purchase Agreement under the
	2010 Performance Incentive Plan
 | 
|  |  |  |  | 
	 
 | 
|  | 10.3 |  |  | 
	OncoGenex Pharmaceuticals, Inc. Short Term Incentive Awards Program
 | 
 
	 
	3
 
	 
	SIGNATURES
	 
	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
	caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
	 
|  |  |  |  |  |  |  |  |  | 
|  |  | ONCOGENEX PHARMACEUTICALS, INC. |  |  | 
|  |  | (Registrant) | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	Date: June 14, 2010  
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
|  |  | By: |  | /s/ Cameron Lawrence |  |  | 
|  |  |  |  |  |  |  | 
| 
	   
 |  |  |  | Name: |  | Cameron Lawrence |  |  | 
| 
	   
 |  |  |  | Title: |  | Principal Financial Officer |  |  | 
 
	 
	4
 
	 
	EXHIBIT INDEX
|  |  |  |  |  | 
| Exhibit No. |  | Description | 
|  |  |  |  | 
	 
 | 
|  | 3.1 |  |  | 
	Fourth Amended and Restated Bylaws of OncoGenex Pharmaceuticals, Inc.
 | 
|  |  |  |  | 
	 
 | 
|  | 3.2 |  |  | 
	Certificate of Amendment of Certificate of Incorporation of OncoGenex Pharmaceuticals, Inc.
 | 
|  |  |  |  | 
	 
 | 
|  | 10.1 |  |  | 
	Form of OncoGenex Pharmaceuticals, Inc. 2010 Stock Option Agreement under the 2010 Performance
	Incentive Plan
 | 
|  |  |  |  | 
	 
 | 
|  | 10.2 |  |  | 
	Form of OncoGenex Pharmaceuticals, Inc. 2010 Restricted Stock Purchase Agreement under the
	2010 Performance Incentive Plan
 | 
|  |  |  |  | 
	 
 | 
|  | 10.3 |  |  | 
	OncoGenex Pharmaceuticals, Inc. Short Term Incentive Awards Program
 | 
 
	 
	5
 
	Exhibit 3.1
	FOURTH AMENDED AND RESTATED
	BYLAWS
	OF
	ONCOGENEX PHARMACEUTICALS, INC.
	Section 1. Law, Certificate of Incorporation and Bylaws.
	1.1. These bylaws are subject to the certificate of incorporation of the corporation. In
	these bylaws, references to law, the certificate of incorporation and bylaws mean the law, the
	provisions of the certificate of incorporation and the bylaws as from time to time in effect.
	Section 2. Stockholders.
	2.1.
	Annual Meeting
	. The annual meeting of stockholders shall be held at such date
	and time as shall be designated from time to time by the board of directors and stated in the
	notice of the meeting, at which they shall elect a board of directors and transact such other
	business as may be required by law or these bylaws or as may properly come before the meeting.
	2.2.
	Special Meetings
	. A special meeting of the stockholders may be called at any
	time by the chairman of the board, if any, the president or the board of directors. A special
	meeting of the stockholders shall be called by the secretary, or in the case of the death, absence,
	incapacity or refusal of the secretary, by an assistant secretary or some other officer, upon
	application of a majority of the directors. Any such application shall state the purpose or
	purposes of the proposed meeting. Any such call shall state the place, date, hour, and purposes of
	the meeting.
	2.3.
	Place of Meeting
	. All meetings of the stockholders for the election of directors
	or for any other purpose shall be held at such place within or without the State of Delaware as may
	be determined from time to time by the chairman of the board, if any, the president or the board of
	directors. Any adjourned session of any meeting of the stockholders shall be held at the place
	designated in the vote of adjournment.
	2.4.
	Notice of Meetings
	. Except as otherwise provided by law, a written notice of
	each meeting of stockholders stating the place, day and hour thereof and, in the case of a special
	meeting, the purposes for which the meeting is called, shall be given not less than ten nor more
	than sixty days before the meeting, to each stockholder entitled to vote thereat, and to each
	stockholder who, by law, by the certificate of incorporation or by these bylaws, is entitled to
	notice, by leaving such notice with him or at his residence or usual place of business, or by
	depositing it in the United States mail, postage prepaid, and addressed to such stockholder at his
	address as it appears in the records of the corporation. Such notice shall be given by the
	secretary, or by an officer or person designated by the board of directors, or in the case of a
	special meeting by the officer calling the meeting. As to any adjourned session of any meeting of
	stockholders, notice of the adjourned meeting need not be given if the time and place
	 
	 
 
	 
	thereof are
	announced at the meeting at which the adjournment was taken except that if the adjournment is for more than thirty days or if after the adjournment a new record date is set for the
	adjourned session, notice of any such adjourned session of the meeting shall be given in the manner
	heretofore described. No notice of any meeting of stockholders or any adjourned session thereof
	need be given to a stockholder if a written waiver of notice, executed before or after the meeting
	or such adjourned session by such stockholder, is filed with the records of the meeting or if the
	stockholder attends such meeting without objecting at the beginning of the meeting to the
	transaction of any business because the meeting is not lawfully called or convened. Neither the
	business to be transacted at, nor the purpose of, any meeting of the stockholders or any adjourned
	session thereof need be specified in any written waiver of notice.
	2.5.
	Quorum of Stockholders
	. At any meeting of the stockholders a quorum as to any
	matter shall consist of a majority of the votes entitled to be cast on the matter, except where a
	larger quorum is required by law, by the certificate of incorporation or by these bylaws. Any
	meeting may be adjourned from time to time by a majority of the votes properly cast upon the
	question, whether or not a quorum is present. If a quorum is present at an original meeting, a
	quorum need not be present at an adjourned session of that meeting. Shares of its own stock
	belonging to the corporation or to another corporation, if a majority of the shares entitled to
	vote in the election of directors of such other corporation is held, directly or indirectly, by the
	corporation, shall neither be entitled to vote nor be counted for quorum purposes; provided,
	however, that the foregoing shall not limit the right of any corporation to vote stock, including
	but not limited to its own stock, held by it in a fiduciary capacity.
	2.6.
	Action by Vote
	. When a quorum is present at any meeting, a plurality of the
	votes properly cast for election to any office shall elect to such office and a majority of the
	votes properly cast upon any question other than an election to an office shall decide the
	question, except when a larger vote is required by law, by the certificate of incorporation or by
	these bylaws. No ballot shall be required for any election unless requested by a stockholder
	present or represented at the meeting and entitled to vote in the election.
	2.7.
	Proxy Representation
	. Every stockholder may authorize another person or persons
	to act for him by proxy in all matters in which a stockholder is entitled to participate, whether
	by waiving notice of any meeting, objecting to or voting or participating at a meeting, or
	expressing consent or dissent without a meeting. Every proxy must be signed by the stockholder or
	by his attorney-in-fact. No proxy shall be voted or acted upon after three years from its date
	unless such proxy provides for a longer period. A duly executed proxy shall be irrevocable if it
	states that it is irrevocable and, if, and only as long as, it is coupled with an interest
	sufficient in law to support an irrevocable power. A proxy may be made irrevocable regardless of
	whether the interest with which it is coupled is an interest in the stock itself or an interest in
	the corporation generally. The authorization of a proxy may but need not be limited to specified
	action, provided, however, that if a proxy limits its authorization to a meeting or meetings of
	stockholders, unless otherwise specifically provided such proxy shall entitle the holder thereof to
	vote at any adjourned session but shall not be valid after the final adjournment thereof.
	 
	-2-
 
	 
	2.8.
	Inspectors
	. The directors or the person presiding at the meeting may, but need
	not, appoint one or more inspectors of election and any substitute inspectors to act at the meeting
	or any adjournment thereof. Each inspector, before entering upon the discharge of his duties,
	shall take and sign an oath faithfully to execute the duties of inspector at such meeting with
	strict
	impartiality and according to the best of his ability. The inspectors, if any, shall
	determine the number of shares of stock outstanding and the voting power of each, the shares of
	stock represented at the meeting, the existence of a quorum, the validity and effect of proxies,
	and shall receive votes, ballots or consents, hear and determine all challenges and questions
	arising in connection with the right to vote, count and tabulate all votes, ballots or consents,
	determine the result, and do such acts as are proper to conduct the election or vote with fairness
	to all stockholders. Notwithstanding the foregoing, in the event that a stockholder seeks to
	nominate one or more directors pursuant to Section 3.3 of these bylaws, the directors shall appoint
	two inspectors, who shall not be affiliated with the Corporation, to determine whether a
	stockholder has complied with Section 3.3 of these bylaws. If the inspector shall determine that a
	stockholder has not complied with Section 3.3 of these bylaws, the inspectors shall direct the
	person presiding over the meeting to declare to the meeting that a nomination was not made in
	accordance with the procedures prescribed by the bylaws; and the person presiding over the meeting
	shall so declare to the meeting and the defective nomination shall be disregarded. On request of
	the person presiding at the meeting, the inspectors shall make a report in writing of any
	challenge, question or matter determined by them and execute a certificate of any fact found by
	them.
	2.9.
	List of Stockholders
	. The secretary shall prepare and make, at least ten days
	before every meeting of stockholders, a complete list of the stockholders entitled to vote at such
	meeting, arranged in alphabetical order and showing the address of each stockholder and the number
	of shares registered in his name. The stock ledger shall be the only evidence as to who are
	stockholders entitled to examine such list or to vote in person or by proxy at such meeting.
	Section 3. Board of Directors.
	3.1.
	Number
	. The number of directors which shall constitute the whole board shall not
	be less than three (3). The exact number of directors shall be fixed from time to time by a
	resolution adopted by a majority of directors. The number of directors may be increased at any
	time or from time to time by the directors by vote of a majority of the directors then in office.
	The number of directors may be decreased to any number permitted by the foregoing at any time by
	the directors by vote of a majority of the directors then in office, but only to eliminate
	vacancies existing by reason of the death, resignation or removal of one or more directors.
	Directors need not be stockholders.
	3.2.
	Tenure
	. Except as otherwise provided by law, by the certificate of incorporation
	or by these bylaws, each director shall hold office until the successors of such directors class
	are elected and qualified, or until he sooner dies, resigns, is removed or becomes disqualified.
	 
	-3-
 
	 
	3.3.
	Nomination
	. Only persons who are nominated in accordance with the procedures set
	forth in this Section 3.3 shall be eligible for election as directors. Nominations of persons for
	election to the board of directors may be made by or at the direction of the board of directors or
	by any stockholder of the corporation entitled to vote for the election of directors at the meeting
	who complies with the notice procedures set forth in this Section 3.3. Such nominations, other
	than those made by or at the discretion of the board of directors, shall be made pursuant to timely
	notice in writing to the Secretary. To be timely, a stockholders notice shall be delivered to or
	mailed and received at the principal executive offices of the corporation not less than 45 days nor
	more than 90 days prior to the meeting; provided, however, that in the event that less than 55
	days notice or prior public disclosure of the date of the meeting is given or made to
	stockholders, notice by the stockholder to be timely must be so received not later than the close
	of business on the 10th day following the date on which such notice of the date of the meeting was
	mailed or such public disclosure was made. Such stockholders notice shall set forth (A) as to
	each person whom the stockholder proposes to nominate for election or reelection as a director, (i)
	the name, age, business address and residence address of such person, (ii) the principal occupation
	or employment of such person, (iii) the class and number of shares of the capital stock of the
	corporation which are beneficially owned by such person and (iv) any other information relating to
	such person that would be required to be disclosed in solicitations of proxies for election of
	directors, or would be otherwise required, in each case pursuant to Regulation 14A promulgated
	under the Securities Exchange Act of 1934, as amended (including without limitation such persons
	written consent to being named in the proxy statement as a without limitation such persons written
	consent to being named in the proxy statement as a nominee and to serving as a director if
	elected); and (B) as to the stockholder giving the notice (i) the name and address of such
	stockholder and (ii) the class and number of shares of the capital stock of the corporation which
	are beneficially owned (as defined by Rule 13d-3 of the Securities Exchange Act of 1934, as
	amended) by such stockholder. If requested in writing by the Secretary at least 15 days in advance
	of the annual meeting, a stockholder whose shares are not registered in the name of such
	stockholder on the corporations books shall provide the Secretary, within ten days of such
	request, with documentary support for such claim of beneficial ownership. At the request of the
	board of directors, any person nominated by the board of directors for election as a director shall
	furnish to the Secretary that information required to be set forth in a stockholders notice of
	nomination which pertains to the nominee.
	3.4.
	Powers
	. The business and affairs of the corporation shall be managed by or under
	the direction of the board of directors who shall have and may exercise all the powers of the
	corporation and do all such lawful acts and things as are not by law, the certificate of
	incorporation or these bylaws directed or required to be exercised or done by the stockholders.
	3.5.
	Vacancies
	. Vacancies and any newly created directorships resulting from any
	increase in the number of directors may be filled by vote of the stockholders at a meeting called
	for the purpose, or by a majority of the directors then in office, although less than a quorum, or
	by a sole remaining director. When one or more directors shall resign from the board, effective at
	a future date, a majority of the directors then in office, including those who have resigned, shall
	have power to fill such vacancy or vacancies, the vote or action by writing thereon to take effect
	when such resignation or resignations shall become effective. The directors shall have and may
	exercise all their powers notwithstanding the existence of one or more vacancies in their number,
	subject to any requirements of law or of the certificate of incorporation or of these bylaws as to
	the number of directors required for a quorum or for any vote or other actions.
	 
	-4-
 
	 
	3.6.
	Committees
	. The board of directors may, by vote of a majority of the whole
	board, (a) designate, change the membership of or terminate the existence of any committee or
	committees, each committee to consist of one or more of the directors; (b) designated one or more
	directors as alternate members of any such committee who may replace any absent or disqualified
	member at any meeting of the committee; and (c) determine the extent to which each such committee
	shall have and may exercise the powers of the board of directors in the
	management of the business and affairs of the corporation, including the power to authorize
	the seal of the corporation to be affixed to all papers which require it and the power and
	authority to declare dividends or to authorize the issuance of stock; excepting, however, such
	powers which by law, by the certificate of incorporation or by these or by these bylaws they are
	prohibited from so delegating. In the absence or disqualification of any member of such committee
	and his alternate, if any, the member or members thereof present at any meeting and not
	disqualified from voting, whether or not constituting a quorum, may unanimously appoint another
	member of the board of directors to act at the meeting in the place of any such absent or
	disqualified member. Except as the board of directors may otherwise determine, any committee may
	make rules for the conduct of its business, but unless otherwise provided by the board or such
	rules, its business shall be conducted as nearly as may be in the same manner as is provided by
	these bylaws for the conduct of business by the board of directors. Each committee shall keep
	regular minutes of its meetings and report the same to the board of directors upon request.
	3.7.
	Regular Meetings
	. Regular meetings of the board of directors may be held without
	call or notice at such places within or without the State of Delaware and at such times as the
	board may from time to time determine, provided that notice of the first regular meeting following
	any such determination shall be given to absent directors. A regular meeting of the directors may
	be held without call or notice immediately after and at the same place as the annual meeting of the
	stockholders.
	3.8.
	Special Meetings
	. Special meetings of the board of directors may be held at any
	time and at any place within or without the State of Delaware designated in the notice of the
	meting, when called by the chairman of the board, if any, the president, or by one-third or more in
	number of the directors, reasonable notice thereof being given to each director by the secretary or
	by the chairman of the board, if any, the president or any one of the directors calling the
	meeting.
	3.9
	Notice
	. Any time it is necessary to give notice of a board of directors meeting,
	notice shall be given (i) in person or by telephone to the director at least 24 hours in advance of
	the meeting, (ii) by personally delivering written notice to the directors last known business or
	home address at least 24 hours in advance of the meeting, (iii) by delivering an electronic
	transmission (including, without limitation, via telefacsimile or electronic mail) to the
	directors last known number or address for receiving electronic transmissions of that type at
	least 24 hours in advance of the meeting, (iv) by depositing written notice with a reputable
	delivery service or overnight carrier addressed to the directors last known business or home
	address for delivery to that address no later than the business day preceding the date of the
	meeting or (v) by depositing written notice in the U.S. mail, postage prepaid, addressed to the
	directors last known business or home address no later than the third business day preceding the
	date of the meeting. Notice of a meeting need not be given to any director if a written waiver of
	notice, executed by him, or a waiver sent by electronic transmission by him, in either case before
	or after the meeting, is filed with the records of the meeting, or to any director who attends the
	meeting without protesting prior thereto or at its commencement the lack of notice to him. Neither
	notice of a meeting nor a wavier of a notice need specify the purposes of the meeting.
	 
	-5-
 
	 
	3.10.
	Quorum
	. Except as may be otherwise provided by law, by the certificate of
	incorporation or these bylaws, at any meeting of the directors a majority of the directors then in
	office shall constitute a quorum; a quorum shall not in any case be less than one-third of the
	total number of directors constituting the whole board. Any meeting may be adjourned from time to
	time by a majority of the votes cast upon the question, whether or not a quorum is present, and the
	meeting may be held as adjourned without further notice.
	3.11.
	Action by Vote
	. Except as may be otherwise provided by law, by the certificate
	of incorporation or by these bylaws, when a quorum is present at any meeting the vote of a majority
	of the directors present shall be the act of the board of directors.
	3.12.
	Action Without a Meeting
	. Any action required or permitted to be taken at any
	meeting of the board of directors or a committee thereof may be taken without a meeting if all the
	members of the board or of such committee, as the case may be, consent thereto in writing or by
	electronic transmission, and such writing or writings or electronic transmission or transmissions
	are filed with the records of the meetings of the board or of such committee. Such consent shall
	be treated for all purposes as the act of the board or of such committee, as the case may be.
	3.13.
	Participation in Meetings by Conference Telephone
	. Members of the board of
	directors, or any committee designated by such board, may participate in a meeting of such board or
	committee by means of conference telephone or similar communications equipment by means of which
	all persons participating in the meting can hear each other or by any other means permitted by law.
	Such participation shall constitute presence in person at such meeting.
	3.14.
	Compensation
	. In the discretion of the board of directors, each director may be
	paid such fees for his services as director and be reimbursed from his reasonable expenses incurred
	in the performance of his duties as director as the board of directors from time to time may
	determine. Nothing contained in this section shall be construed to preclude any director from
	serving the corporation in any other capacity and receiving reasonable compensation therefor.
	3.15.
	Interested Directors and Officers
	.
	(a) No contract or transaction between the corporation and one or more of its directors or
	officers, or between the corporation and any other corporation, partnership, association, or other
	organization in which one or more of the corporations directors or officers are directors or
	officers, or have a financial interest, shall be void or voidable, solely for this reason, or
	solely because the director officer is present at or participates in the meeting of the board or
	committee thereof which authorizes the contract or transaction, or solely because his or their
	votes are counted for such purpose, if:
	(1) The material facts as to his relationship or interest and as to the contract or
	transaction are disclosed or are known to the board of directors or the committee, and the board or
	committee in good faith authorizes the contract or transaction by the affirmative votes of majority
	of the disinterested directors, even though the disinterested directors be less than a quorum: or
	 
	-6-
 
	 
	(2) The material facts as to his relationship or interest and as to the contract or
	transaction are disclosed or are known to the stockholder entitled to vote thereon, and the
	contract or transaction is specifically approved in good faith by vote of the stockholders; or
	(3) The contract or transaction is fair as to the corporation as of the time it is authorized,
	approved or ratified by the board of directors, a committee thereof, or the stockholders.
	(b) Common or interested directors may be counted in determining the presence of a quorum at a
	meeting of the board of directors or of a committee which authorized the contract or transaction.
	Section 4. Officers and Agents.
	4.1.
	Enumeration: Qualification
	. The officers of the corporation shall be a
	president, a treasurer, a secretary and such other officers, if any, as the board of directors from
	time to time may in its discretion elect or appoint including without limitation a chairman of the
	board, one or more vice presidents and a controller. The corporation may also have such agents, if
	any, as the board of directors from time to time may in its discretion choose. Any officer may be
	but none need be a director or stockholder. Any two or more offices may be held by the same
	person. Any officer may be required by the board of directors to secure the faithful performance
	of his duties to the corporation by giving bond in such amount and with sureties or otherwise as
	the board of directors may determine.
	4.2.
	Powers
	. Subject to law, to the certificate of incorporation and to the other
	provisions of these bylaws, each officer shall have, in addition to the duties and powers herein
	set forth, such duties and powers as are commonly incident to his office and such additional duties
	and powers as the board of directors may from time to time designate.
	4.3.
	Election
	. The officers may be elected by the board of directors at their first
	meeting following the annual meeting of the stockholders or at any other time. At any time or from
	time to time the directors may delegate to any officer their power to elect or appoint any other
	officer or any agents.
	4.4.
	Tenure
	. Each officer shall hold office until the first meeting of the board of
	directors following the next annual meeting of the stockholders and until his respective successor
	is chosen and qualified unless a shorter period shall have been specified by the terms of his
	election or appointment, or in each case until he sooner dies, resigns, is removed or becomes
	disqualified. Each agent shall retain his authority at the pleasure of the directors, or the
	officer by whom he was appointed or by the officer who then holds agent appointive power.
	4.5.
	Chairman of the board of directors, President and Vice President
	. The chairman
	of the board, if any, shall have such duties and powers as shall be designated from time to time by
	the board of directors. Unless the board of directors otherwise specifies, the chairman of the
	board, or if there is none the chief executive officer, shall preside, or designate the person who
	shall preside, at all meetings of the stockholders and of the board of directors.
	 
	-7-
 
	 
	Unless the board of directors otherwise specifies, the president shall be the chief executive
	officer and shall have direct charge of all business operations of the corporation and, subject to
	the control of the directors, shall have general charge and supervision of the business of the
	corporation.
	Any vice president shall have such duties and powers as shall be set forth in these bylaws or
	as shall be designated from time to time by the board of directors or by the president.
	4.6.
	Chief Financial Officer and Assistant Treasurers
	. Unless the board of directors
	otherwise specifies, the chief financial officer shall be the treasurer of the corporation and
	shall be in charge of its funds and valuable papers, and shall have such other duties and powers as
	may be designated from time to time by the board of directors or by the president. If no
	controller is elected, the chief financial officer shall, unless the board of directors otherwise
	specifies, also have the duties and powers of the controller.
	Any assistant treasurers shall have such duties and powers as shall be designated from time to
	time by the board of directors, the president or the chief financial officer.
	4.7.
	Controller and Assistant Controller
	. If a controller is elected, he shall,
	unless the board of directors otherwise specifies, be the chief accounting officer of the
	corporation and be in charge of its books of account and accounting records, and of its accounting
	procedures. He shall have such other duties and powers and may be designated from time to time by
	the board of directors, the president or the treasurer.
	Any assistant controller shall have such duties and powers as shall be designated from time to
	time by the board of directors, the president, the treasurer or the controller.
	4.8.
	Secretary and Assistant Secretaries
	. The secretary shall record all proceedings
	of the stockholders, of the board of directors and of committees of the board of directors in a
	book or series of books to be kept therefore and shall file therein all actions by written consent
	of stockholders or directors. In the absence of the secretary from any meeting, an assistant
	secretary, or if there be none or he is absent, a temporary secretary chosen at the meeting, shall
	record the proceedings thereof. Unless a transfer agent has been appointed the secretary shall
	keep or cause to be kept the stock and transfer records of the corporation, which shall contain the
	names and record addresses of all stockholders and the number of shares registered in the name of
	each stockholder. He shall have such other duties and powers as may from time to time be
	designated by the board of directors or the president.
	Any assistant secretaries shall have such duties and powers as shall be designated from time
	to time by the board of directors, the president or the secretary.
	 
	-8-
 
	 
	Section 5. Resignations and Removals.
	5.1. Any director or officer may resign at any time by delivering his resignation in writing
	or by electronic transmission to the chairman of the board, if any, the president, or the secretary
	or to a meeting of the board of directors. Such resignation shall be effective upon receipt unless
	specified to be effective at some other time, and without in either case the necessity of its being
	accepted unless the resignation shall so state. A director (including persons
	elected by directors to fill vacancies in the board) may be removed from office with or
	without cause by the vote of the holders of a majority of the shares issued and outstanding and
	entitled to vote in the election of directors. The board of directors may at any time remove any
	officer either with or without cause. The board of directors may at any time terminate or modify
	the authority of any agent. No director of officer resigning and (except where a right to receive
	compensation shall be expressly provided in a duly authorized written agreement with the
	corporation) no director or officer removed shall have any right to any compensation as such
	director or officer for any period following his resignation or removal, or any right to damages on
	account of such removal, whether his compensation be by the month or by the year or otherwise;
	unless, in the case of a resignation, the directors, or, in the case of removal, the body acting on
	the removal, shall in their or its discretion provide for compensation.
	Section 6. Vacancies.
	6.1. If the office of the president or the treasurer or the secretary becomes vacant, the
	directors may elect a successor by vote of a majority of the directors then in office. If the
	office of any other officer becomes vacant, any person or body empowered to elect or appoint that
	officer may choose a successor. Each such successor shall hold office for the unexpired term, and
	in the case of the president, the treasurer and the secretary until his successor is chosen and
	qualified or in each case he sooner dies, resigns, is removed or becomes disqualified. Any vacancy
	of a directorship shall be filled as specified in Section 3.5 of these bylaws.
	Section 7. Capital Stock.
	7.1.
	Stock Certificates
	. The shares of the corporation shall be represented by
	certificates, provided that the board of directors of the corporation may provide by resolution or
	resolutions that some or all of any or all classes or series of its stock shall be uncertificated
	shares. Any such resolution shall not apply to shares represented by a certificate until such
	certificate is surrendered to the corporation. Notwithstanding the adoption of such a resolution
	by the board of directors, every holder of stock represented by certificates and upon request every
	holder of uncertificated shares shall be entitled to have a certificate signed by, or in the name
	of the corporation by the chairman or vice-chairman of the board of directors, if any, or the
	president or vice-president, and by the treasurer or an assistant treasurer, or by the secretary or
	an assistant secretary of such corporation representing the number of shares registered in
	certificate form. Any or all of the signatures on the certificate may be a facsimile. In case any
	officer, transfer agent or registrar who has signed or whose facsimile signature has been placed
	upon a certificate has ceased to be such officer, transfer agent or registrar before such
	certificate is issued, it may be issued by the corporation with the same effect as if he were such
	officer, transfer agent, or registrar at the time of issue.
	7.2.
	Loss of Certificates
	. In the case of the alleged theft, loss, destruction or
	mutilation of a certificate of stock, a duplicate certificate may be issued in place thereof, upon
	such terms, including receipt of a bond sufficient to indemnify the corporation against any claim
	on account thereof, as the board of directors may prescribe.
	 
	-9-
 
	 
	Section 8. Transfer of Shares of Stock.
	8.1.
	Transfer on Books
	. Subject to the restrictions, if any, stated or noted on the
	stock certificate, shares of stock may be transferred on the books of the corporation by the
	surrender to the corporation or its transfer agent of the certificate therefor properly endorsed or
	accompanied by a written assignment and power of attorney properly executed, with necessary
	transfer stamps affixed, and with such proof of the authenticity of signature as the board of
	directors or the transfer agent of the corporation may reasonably require. Except as may be
	otherwise required by law, by the certificate of incorporation or by these bylaws, the corporation
	shall be entitled to treat the record holder of stock as shown on its books as the owner of such
	stock for all purposes, including the payment of dividends and the right to receive notice and to
	vote or to give any consent with respect thereto and to be held liable for such calls and
	assessments, if any, as may lawfully be made thereon, regardless of any transfer, pledge or other
	disposition of such stock until the shares have been properly transferred on the books of the
	corporation.
	It shall be the duty of each stockholder to notify the corporation of his post office address.
	8.2.
	Record Date and Closing Transfer Books
	. In order that the corporation may
	determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any
	adjournment thereof, the board of directors may fix a record date, which record date shall not
	precede the date upon which the resolution fixing the record date is adopted by the board of
	directors, and which record date shall not be more than sixty nor less than ten days before the
	date of such meeting. If no such record date is fixed by the board of directors, the record date
	for determining the stockholders entitled to notice of or to vote at a meeting of stockholders
	shall be at the close of business on the day next preceding the day on which notice is given, or,
	if notice is waived, at the close of business on the day next preceding the day on which the
	meeting is held. A determination of stockholders or record entitled to notice of or to vote at a
	meeting of stockholders shall apply to any adjournment of the meeting; provided, however, that the
	board of directors may fix a new record date for the adjourned meeting.
	In order that the corporation may determine the stockholders entitled to receive payment of
	any dividend or other distribution or allotment of any rights or to exercise any rights in respect
	of any change, conversion or exchange of stock, or for the purpose of any other lawful action, the
	board of directors may fix a record date, which record date shall not precede the date upon which
	the resolution fixing the record date is adopted, and which record date shall be not more than
	sixty days prior to such payment, exercise or other action. If no such record date is fixed, the
	record date for determining stockholders for any such purpose shall be at the close of business on
	the day on which the board of directors adopts the resolution relating thereto.
	 
	-10-
 
	 
	Section 9. Indemnification.
	9.1.
	Right to Indemnification
	. Each person who was or is made a party or is
	threatened to be made a party to or is otherwise involved in any action, suit or proceeding,
	whether civil, criminal, administrative or investigative (hereinafter a proceeding), by reason of
	the fact that he or she is or was a director officer of the corporation or is or was serving at the
	request of the corporation as a director or officer of another corporation or of a partnership,
	joint
	venture, trust or other enterprise, including service with respect to employee benefit plans
	(hereinafter an indemnitee), whether the basis of such proceeding is alleged action in an
	official capacity as a director or officer or in any other capacity while serving as a director or
	officer, shall be indemnified and held harmless by the corporation to the fullest extent authorized
	by the Delaware General Corporation Law, as the same exists or may hereafter be amended (but, in
	the case of any such amendment, only to the extent that such amendment permits the corporation to
	provide broader indemnification rights than such law permitted the corporation to provide prior to
	such amendment), against all expense, liability and loss (including attorneys fees, judgments,
	fines, ERISA excise taxes or penalties and amounts paid in settlement) reasonably incurred or
	suffered by such indemnitee in connection therewith and such indemnification shall continue as to
	an indemnitee who has ceased to be a director or officer and shall inure to the benefit of the
	indemnitees heirs, executors and administrators; provided, however, that, except as provided in
	this Section 9.1 with respect to proceedings to enforce rights to indemnification, the corporation
	shall indemnify any such indemnitee in connection with a proceeding (or part thereof) initiated by
	such indemnitee only if such proceeding (or part thereof) was authorized by the board of directors
	of the corporation. The right to indemnification conferred in this Section 9.1 shall be a contract
	right and shall include the right to be paid by the corporation the expenses incurred in defending
	any such proceeding in advance of its final disposition (hereinafter an advancement of expenses);
	provided, however, that, if the Delaware General Corporation Law requires, an advancement of
	expenses incurred by an indemnitee in his or her capacity as a director or officer (and not in any
	other capacity in which service was or is rendered by such indemnitee, including without
	limitation, service to an employee benefit plan) shall be made only upon delivery to the
	corporation of an undertaking, by or on behalf of such indemnitee, to repay all amounts so advanced
	if it shall ultimately be determined by final judicial decision from which there is not further
	right to appeal that such indemnitee is not entitled to be indemnified for such expenses under this
	Section 9 or otherwise (hereinafter an undertaking).
	9.2.
	Right of Indemnitee to Bring Suit
	. If a claim under Section 9.1 of these bylaws
	is not paid in full by the corporation within forty-five (45) days after a written claim has been
	received by the corporation, the indemnitee may at any time thereafter bring suit against the
	corporation to recover the unpaid amount of the claim. If successful in whole or part in any such
	suit or in a suit brought by the corporation to recover an advancement of expenses pursuant to the
	terms of an undertaking, the indemnitee shall be entitled to be paid also the expense of
	prosecuting or defending such suit. In (i) any suit brought by the indemnitee to enforce a right
	to indemnification hereunder (but not in a suit brought by the indemnitee to enforce a right to an
	advancement of expenses) it shall be a defense that, and (ii) any suit by the corporation to
	recover an advancement of expenses pursuant to the terms of an undertaking the corporation shall be
	entitled to recover such expenses upon a final adjudication that, the indemmitee has not met the
	applicable standard of conduct set forth in the Delaware General Corporation Law. Neither the
	failure of the corporation (including its board of directors, independent legal counsel, or its
	stockholders) to have made a determination prior to the commencement of such suit that
	indemnification of the indemnitee is proper in the circumstances because the indemnitee has met the
	applicable standard of conduct set forth in the Delaware General Corporation Law, nor an actual
	determination by the corporation (including its board of directors, independent legal counsel, or
	its stockholders) that the indemnitee has not met such applicable standard of conduct, shall create
	a presumption that the indemnitee has not met the applicable standard of conduct or, in the case of
	such a suit brought by indemnitee, be a defense to such suit. In any suit brought by
	the indemnitee to enforce a right hereunder, or by the corporation to recover an advancement
	of expenses pursuant to the terms of an undertaking, the burden of proving that the indemnitee is
	not entitled to be indemnified or to such advancement of expenses under this Section 9 or otherwise
	shall be on the corporation.
	 
	-11-
 
	 
	9.3.
	Non-Exclusivity of Rights
	. The rights of indemnification and to the advancement
	of expenses conferred in this Section 9 shall not be exclusive of any other right which any person
	may have or thereafter acquire under any statue, provision of the Certificate of Incorporation,
	by-law agreement, vote of stockholders or disinterested directors or otherwise and shall inure to
	the benefit of the heirs and legal representatives of such person.
	9.4.
	Insurance
	. The corporation may maintain insurance, at its expense, to protect
	itself and any director, officer, employee or agent of the corporation or another corporation,
	partnership, joint venture, trust or other enterprise against any expense, liability or loss,
	whether or not the corporation would have the power to indemnify such person against such expense,
	liability or loss under the Delaware General Corporation Law.
	9.5.
	Indemnification of Employees or Agents of the Corporation
	. The corporation may,
	to the extent authorized from time to time by the board of directors, grant rights to
	indemnification and to the advancement of expenses, to any employee or agent of the corporation to
	the fullest extent of the provisions of this Section 9 with respect to the indemnification and
	advancement of expenses of directors or officers of the corporation.
	9.6.
	Indemnification Contracts
	. The board of directors is authorized to enter into a
	contract with any director, officer, employee or agent of the corporation, or any person serving at
	the request of the corporation as a director, officer, employee or agent of another corporation,
	partnership, joint venture, trust or other enterprise, including employee benefit plans, providing
	for indemnification rights equivalent to or, if the board of directors so determines, greater than,
	those provided for in this Section 9.
	9.7.
	Effect of Amendment
	. Any amendment, repeal or modification of any provision of
	this Section 9 by the stockholders or the directors of the corporation shall not adversely affect
	any right or protection of a director or officer of the corporation existing at the time of such
	amendment, repeal or modification.
	Section 10. General Provisions.
	10.1.
	Corporate Seal
	. Subject to alteration by the directors, the seal of the
	corporation shall consist of a flat-faced circular die with the word Delaware and the name of the
	corporation cut or engraved thereon, together with such other words, dates or images as may be
	approved from time to time by the directors.
	10.2.
	Execution of Papers
	. Except as the board of directors may generally or in
	particular cases authorize the execution thereof in some other manner, all deeds, leases,
	transfers, contracts, bonds, notes, checks, drafts or other obligations made, accepted or endorsed
	by the corporation shall be signed by the chairman of the board, if any, the president, a vice
	president or the treasurer.
	 
	-12-
 
	 
	10.3.
	Fiscal Year
	. The fiscal year of the corporation shall be fixed by resolution
	of the Board of Directors.
	10.4.
	Electronic Transmission
	. For purposes of these bylaws, electronic
	transmission shall mean a form of communication not directly involving the physical transmission
	of paper that satisfies the requirements with respect to such communications contained in the
	Delaware General Corporation Law.
	10.5. Amendments. These bylaws may be adopted, amended or repealed by vote of a majority of
	the directors then in office or by vote of a majority of the stock outstanding and entitled to
	vote. Any by-law, whether adopted, amended or repealed by the stockholders or directors, may be
	amended or reinstated by the stockholders or the directors.
	 
	-13-
 
	Exhibit 10.1
	Option No.
	ONCOGENEX PHARMACEUTICALS, INC.
	STOCK OPTION AGREEMENT
	Type of Option (check one):
	o
	Incentive
	o
	Nonqualified
	This Stock Option Agreement (the Agreement) is entered into as of
	                    
	,
	20
	     
	, by and between OncoGenex Pharmaceuticals, Inc., a Delaware corporation (the
	Company), and
	                    
	(the Optionee) pursuant to the Companys
	2010 Performance Incentive Plan, as amended (the Plan). Any capitalized term not defined herein
	shall have the same meaning ascribed to it in the Plan.
	1. 
	Grant of Option
	. The Company hereby grants to Optionee an option (the Option) to
	purchase all or any portion of a total of
	                    
	(
	          
	) shares
	(the Shares) of the Common Stock of the Company at a purchase price of
	                    
	($
	          
	) per share (the Exercise Price), subject to
	the terms and conditions set forth herein and the provisions of the Plan. If the box marked
	Incentive above is checked, then this Option is intended to qualify as an incentive stock
	option as defined in Section 422 of the Internal Revenue Code of 1986, as amended (the Code).
	If this Option fails in whole or in part to qualify as an incentive stock option, or if the box
	marked Nonqualified is checked, then this Option shall to that extent constitute a nonqualified
	stock option.
	2. 
	Vesting of Option
	. The right to exercise this Option shall vest in installments,
	and this Option shall be exercisable from time to time in whole or in part as to any vested
	installment, as follows:
|  |  |  | 
| Upon the date set forth below: |  | This Option shall be Exercisable as to: | 
| 
	 
 |  | Shares | 
| 
	 
 |  | Shares | 
| 
	 
 |  | Shares | 
 
	No additional Shares shall vest after the date of termination of Optionees Continuous
	Service (as defined below), but this Option shall continue to be exercisable in accordance with
	Section 3 hereof with respect to that number of Shares that have vested as of the date of
	termination of Optionees Continuous Service.
	As used herein, the term Continuous Service means (i) employment by either the Company or
	any parent or subsidiary corporation of the Company, or by a corporation or a parent or subsidiary
	of a corporation issuing or assuming a stock option in a transaction to which Section 424(a) of the
	Code applies, which is uninterrupted except for vacations, illness (except for permanent
	disability, as defined in Section 22(e)(3) of the Code), or leaves of absence which are approved in
	writing by the Company or any of such other employer corporations, if applicable, (ii) service as a
	member of the Board of Directors of the Company until Optionee resigns, is removed from office, or
	Optionees term of office expires and he or she is not
	reelected, or (iii) so long as Optionee is engaged as a Service Provider to the Company or
	other corporation referred to in clause (i) above.
	 
	 
 
	 
	3. 
	Term of Option
	. The right of the Optionee to exercise this Option shall terminate
	upon the first to occur of the following:
	(a) the expiration of ten (10) years from the date of this Agreement;
	(b) the expiration of three (3) months from the date of termination of Optionees Continuous
	Service if such termination occurs for any reason other than permanent disability or death;
	provided, however, that if Optionee dies during such three-month period the provisions of Section
	3(d) below shall apply; and provided, further, that if Section 3(d) does not apply, and on the last
	trading day within such three-month period Optionee is subject to a blackout imposed by the Company
	pursuant to which Optionee is restricted from exercising this Option or reselling the Shares
	issuable upon such exercise, the right of Optionee to exercise this Option shall continue until the
	tenth (10
	th
	) day following the expiration of such blackout with respect to Optionee;
	(c) the expiration of one (1) year from the date of termination of Optionees Continuous
	Service if such termination is due to permanent disability of the Optionee (as defined in Section
	22(e)(3) of the Code);
	(d) the expiration of one (1) year from the date of termination of Optionees Continuous
	Service if such termination is due to Optionees death or if death occurs during the three-month
	period following termination of Optionees Continuous Service specified in Section 3(b) above; or
	(e) upon the consummation of a Change in Control (as defined in Section 2.7 of the Plan).
	4. 
	Exercise of Option
	. On or after the vesting of any portion of this Option in
	accordance with Sections 2 or 8 hereof, and until termination of the right to exercise this Option
	in accordance with Section 3 above, the portion of this Option which has vested may be exercised in
	whole or in part by the Optionee (or, after his or her death, by the person designated in Section 5
	below) upon delivery of the following to the Company at its principal executive offices:
	(a) a written notice of exercise which identifies this Agreement and states the number of
	Shares then being purchased (but no fractional Shares may be purchased);
	(b) a check or cash in the amount of the Exercise Price (or payment of the Exercise Price in
	such other form of lawful consideration as the Administrator may approve from time to time under
	the provisions of Section 5.3 of the Plan);
	(c) a check or cash in the amount reasonably requested by the Company to satisfy the Companys
	withholding obligations under federal, state or other applicable tax laws with respect to the
	taxable income, if any, recognized by the Optionee in connection with the exercise of this Option
	(unless the Company and Optionee shall have made other arrangements
	for deductions or withholding from Optionees wages, bonus or other compensation payable to
	Optionee, or by the withholding of Shares issuable upon exercise of this Option or the delivery of
	Shares owned by the Optionee in accordance with Section 11.1 of the Plan, provided such
	arrangements satisfy the requirements of applicable tax laws); and
	 
	Page 2 of 6
 
	 
	(d) a letter, if requested by the Company, in such form and substance as the Company may
	require, setting forth the investment intent of the Optionee, or person designated in Section 5
	below, as the case may be.
	5. 
	Death of Optionee; No Assignment
	. The rights of the Optionee under this Agreement
	may not be assigned or transferred except by will or by the laws of descent and distribution, and
	may be exercised during the lifetime of the Optionee only by such Optionee. Any attempt to sell,
	pledge, assign, hypothecate, transfer or dispose of this Option in contravention of this Agreement
	or the Plan shall be void and shall have no effect. If the Optionees Continuous Service
	terminates as a result of his or her death, and provided Optionees rights hereunder shall have
	vested pursuant to Section 2 hereof, Optionees legal representative, his or her legatee, or the
	person who acquired the right to exercise this Option by reason of the death of the Optionee
	(individually, a Successor) shall succeed to the Optionees rights and obligations under this
	Agreement. After the death of the Optionee, only a Successor may exercise this Option.
	6. 
	Representation of Optionee
	. Optionee acknowledges receipt of a copy of the Plan
	and understands that all rights and obligations connected with this Option are set forth in this
	Agreement and the Plan.
	7. 
	Adjustments Upon Changes in Capital Structure
	. In the event that the outstanding
	shares of Common Stock of the Company are hereafter increased or decreased or changed into or
	exchanged for a different number or kind of shares or other securities of the Company by reason of
	a recapitalization, stock split, reverse stock split, reclassification, stock dividend or other
	similar change in the capital structure of the Company, then appropriate adjustment shall be made
	by the Administrator to the number of Shares subject to the unexercised portion of this Option and
	to the Exercise Price per Share, in order to preserve, as nearly as practical, but not to increase,
	the benefits of the Optionee under this Option, in accordance with the provisions of Section 4.2 of
	the Plan.
	8. 
	Change in Control
	. In the event of a Change in Control (as defined in Section 2.7
	of the Plan), the right to exercise this Option shall accelerate automatically and vest in full
	(notwithstanding the provisions of Section 2 above) effective as of immediately prior to the
	consummation of the Change in Control. If vesting of this Option will accelerate pursuant to the
	preceding sentence, the Administrator in its discretion may provide, in connection with the Change
	in Control transaction, for the purchase or exchange of this Option for an amount of cash or other
	property having a value equal to the difference (or spread) between: (x) the value of the cash
	or other property that the Optionee would have received pursuant to the Change in Control
	transaction in exchange for the Shares issuable upon exercise of this Option had this Option been
	exercised immediately prior to the Change in Control, and (y) the aggregate Exercise Price for such
	Shares. If the vesting of this Option will accelerate pursuant to this Section 8, then the
	Administrator shall cause written notice of the Change in Control transaction
	to be given to the Optionee not less than fifteen (15) days prior to the anticipated effective
	date of the proposed transaction.
	 
	Page 3 of 6
 
	 
	9. 
	Rights as Stockholder
	. The Optionee (or transferee of this Option by will or by
	the laws of descent and distribution) shall have no rights as a stockholder with respect to any
	Shares covered by this Option until such person has duly exercised this Option, paid the Exercise
	Price and become a holder of record of the Shares purchased.
	10. 
	Market Stand-Off Agreement
	. Optionee agrees that, if requested by the Company
	or the managing underwriter of any proposed public offering of the Companys securities, Optionee
	will not sell or otherwise transfer or dispose of any Shares held by Optionee without the prior
	written consent of the Company or such underwriter, as the case may be, during such period of time,
	not to exceed 180 days following the effective date of the registration statement filed by the
	Company with respect to such offering, as the Company or the underwriter may specify.
	11. 
	Interpretation
	. This Option is granted pursuant to the terms of the Plan, and
	shall in all respects be interpreted in accordance therewith. The Administrator shall interpret
	and construe this Option and the Plan, and any action, decision, interpretation or determination
	made in good faith by the Administrator shall be final and binding on the Company and the Optionee.
	As used in this Agreement, the term Administrator shall refer to the committee of the Board of
	Directors of the Company appointed to administer the Plan, and if no such committee has been
	appointed, the term Administrator shall mean the Board of Directors.
	12. 
	Limitation of Liability for Nonissuance
	. During the term of the Plan, the Company
	agrees at all times to reserve and keep available, and to use its reasonable best efforts to obtain
	from any regulatory body having jurisdiction any requisite authority in order to issue and sell,
	such number of shares of its Common Stock as shall be sufficient to satisfy its obligations
	hereunder and the requirements of the Plan. Inability of the Company to obtain, from any
	regulatory body having jurisdiction, authority deemed by the Companys counsel to be necessary for
	the lawful issuance and sale of any shares of its Common Stock hereunder and under the Plan shall
	relieve the Company of any liability in respect of the nonissuance or sale of such shares as to
	which such requisite authority shall not have been obtained.
	13. 
	Notices
	. Any notice, demand or request required or permitted to be given under
	this Agreement shall be in writing and shall be deemed given when delivered personally or three (3)
	days after being deposited in the United States mail, as certified or registered mail, with postage
	prepaid, (or by such other method as the Administrator may from time to time deem appropriate), and
	addressed, if to the Company, at its principal place of business, Attention: the Chief Financial
	Officer, and if to the Optionee, at his or her most recent address as shown in the employment or
	stock records of the Company.
	14. 
	Severability
	. Should any provision or portion of this Agreement be held to be
	unenforceable or invalid for any reason, the remaining provisions and portions of this Agreement
	shall be unaffected by such holding.
	 
	Page 4 of 6
 
	 
	15. 
	Counterparts
	. This Agreement may be executed in two or more counterparts, each of
	which shall be deemed an original and all of which together shall be deemed one instrument.
	16. 
	Tax Consequences and Reporting Obligation Upon Sale of Shares
	. If this Option is
	an incentive stock option, the tax benefits afforded to incentive stock options will be obtained
	by the Optionee only if the Shares received upon exercise of this Option are held for at least one
	year after the date of exercise of this Option and two years after the date this Option was granted
	to the Optionee. If the Optionee sells or otherwise transfers the Shares before the expiration of
	either of these one- or two-year periods, the sale or transfer will be treated for tax purposes as
	a disqualifying disposition, resulting in the following tax consequences: (a) the Optionee will
	not obtain the tax benefits afforded to incentive stock options, (b) the spread as of the date of
	exercise will be taxed to the Optionee at ordinary income tax rates, and (c) the amount of ordinary
	income resulting from the disqualifying disposition will be included in the Optionees W-2. These
	tax consequences are described in more detail in the prospectus that relates to the Plan, a copy of
	which was delivered to the Optionee with this Option. To assure that the Company has the
	information necessary to comply with its tax reporting obligations, Optionee agrees to promptly
	notify the Company if any Shares are sold or transferred less than one year after the date of
	exercise or less than two years after the date this Option was granted, and report information
	regarding the disqualifying disposition in accordance with procedures established by the Company
	for this purpose.
	 
	Page 5 of 6
 
	 
	IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
	written.
|  |  |  |  |  |  |  |  |  | 
| ONCOGENEX PHARMACEUTICALS, INC. |  | OPTIONEE |  |  | 
| a Delaware corporation |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	By:
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  | (Signature) |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	Name:
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  | (Type or print name) |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	Its:
 |  |  |  |  |  | Address: |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
 
	 
	Page 6 of 6
 
	Exhibit 10.2
	ONCOGENEX PHARMACEUTICALS, INC.
	RESTRICTED STOCK PURCHASE AGREEMENT
	UNDER THE
	2010 PERFORMANCE INCENTIVE PLAN
	THIS RESTRICTED STOCK PURCHASE AGREEMENT (the Agreement) is entered into as of
	                    
	, 20
	          
	by and between
	        
	(hereinafter
	referred to as Purchaser), and OncoGenex Pharmaceuticals, Inc., a Delaware corporation
	(hereinafter referred to as the Company), pursuant to the Companys 2010 Performance Incentive
	Plan, as amended (the Plan). Any capitalized term not defined herein shall have the same meaning
	ascribed to it in the Plan.
	R E C I T A L S:
	A. 
	Purchaser is an employee, director, consultant or other Service Provider, and in connection
	therewith has rendered services for and on behalf of the Company.
	B. 
	The Company desires to issue shares of Common Stock to Purchaser for the consideration set
	forth herein to provide an incentive for Purchaser to remain a Service Provider of the Company and
	to exert added effort towards its growth and success.
	NOW, THEREFORE, in consideration of the mutual covenants hereinafter set forth, and for other
	good and valuable consideration, the parties agree as follows:
	1. Issuance of Shares
	. The Company hereby offers to issue to Purchaser an aggregate of
	                    
	 (
	          
	) shares of Common Stock of the Company (the Shares) on the terms and
	conditions herein set forth. Unless this offer is earlier revoked in writing by the Company,
	Purchaser shall have ten (10) days from the date of the delivery of this Agreement to Purchaser to
	accept the offer of the Company by executing and delivering to the Company two copies of this
	Agreement, without condition or reservation of any kind whatsoever, together with the consideration
	to be delivered by Purchaser pursuant to Section 2 below.
	2. Consideration
	. The purchase price for the Shares shall be $
	          
	 per share, or $
	          
	in the aggregate. Any purchase price more than zero shall be paid by the delivery of Purchasers
	check payable to the Company (or payment in such other form of lawful consideration as the
	Administrator may approve from time to time under the provisions of Section 6.3 of the Plan).
	3. Vesting of Shares
	.
	(a) 
	Subject to Section 3(b) below, the Shares acquired hereunder shall vest and become Vested
	Shares as follows:
|  |  |  | 
| Upon the date set forth below: |  | Shares that become Vested Shares: | 
| 
	 
 |  | Shares | 
| 
	 
 |  | Shares | 
| 
	 
 |  | Shares | 
 
	 
	 
 
	 
	Shares which have not yet become vested are herein called Unvested Shares. No additional Shares
	shall vest after the date of termination of Purchasers Continuous Service.
	As used herein, the term Continuous Service means (i) employment by either the Company or
	any parent or subsidiary corporation of the Company, or by any successor entity following a Change
	in Control, which is uninterrupted except for vacations, illness (except for permanent disability,
	as defined in Section 22(e)(3) of the Code), or leaves of absence which are approved in writing by
	the Company or any of such other employer corporations, if applicable, (ii) service as a member of
	the Board of Directors of the Company until Purchaser resigns, is removed from office, or
	Purchasers term of office expires and he or she is not reelected, or (iii) so long as Purchaser is
	engaged as a consultant or Service Provider to the Company or other corporation referred to in
	clause (i) above.
	(b) 
	Notwithstanding Section 3(a), if Purchaser holds Shares at the time a Change in Control
	occurs, all Repurchase Rights (as defined below) shall automatically terminate immediately prior to
	the consummation of such Change in Control, and the Shares subject to those terminated Repurchase
	Rights shall immediately vest in full. If the Repurchase Rights automatically terminate in
	accordance with the provisions of this subsection (b), then the Administrator shall cause written
	notice of the Change in Control transaction to be given to Purchaser not less than fifteen (15)
	days prior to the anticipated effective date of the proposed transaction.
	4. Reconveyance Upon Termination of Service
	.
	(a) Repurchase Right
	. The Company shall have the right (but not the obligation) to repurchase
	all or any part of the Unvested Shares (the Repurchase Right) in the event that the Purchasers
	Continuous Service terminates for any reason. Upon exercise of the Repurchase Right, the Purchaser
	shall be obligated to sell his or her Unvested Shares to the Company, as provided in this Section
	4. If the Purchase Price is zero, then Purchaser shall be obligated to transfer his or her
	Unvested Shares to the Company without consideration.
	(b) Consideration for Repurchase Right
	. The repurchase price of the Unvested Shares (the
	Repurchase Price) shall be equal to the Purchase Price, if any, of such Unvested Shares.
	(c) Procedure for Exercise of Reconveyance Option
	. For sixty (60) days after the date of
	termination of Purchasers Continuous Service or other event described in this Section 4, the
	Company may exercise the Repurchase Right by giving Purchaser and/or any other person obligated to
	sell written notice of the number of Unvested Shares which the Company desires to purchase. The
	Repurchase Price for the Unvested Shares shall be payable, at the option of the Company, by check
	or by cancellation of all or a portion of any outstanding indebtedness of Purchaser to the Company,
	or by any combination thereof.
	 
	Page 2 of 7
 
	 
	(d) Notification and Settlement
	. In the event that the Company has elected to exercise the
	Repurchase Right as to part or all of the Unvested Shares within the period described above,
	Purchaser or such other person shall deliver to the Company certificate(s) representing the
	Unvested Shares to be acquired by the Company within thirty (30)
	days following the date of the notice from the Company. The Company shall deliver to
	Purchaser against delivery of the Unvested Shares, checks of the Company payable to Purchaser
	and/or any other person obligated to transfer the Unvested Shares in the aggregate amount of the
	Repurchase Price, if any, to be paid as set forth in Section 4(b) above.
	(e) Deposit of Unvested Shares
	. Purchaser shall deposit with the Company certificates
	representing the Unvested Shares, together with a duly executed stock assignment separate from
	certificate in blank, which shall be held by the Secretary of the Company. Purchaser shall be
	entitled to vote and to receive dividends and distributions on all such deposited Unvested Shares.
	(f) Termination
	. The provisions of this Section 4 shall automatically terminate in accordance
	with Section 3(b) above.
	(g) Assignment
	. The Company may assign its Repurchase Right under this Section 4 without the
	consent of the Purchaser.
	5. Restrictions on Unvested Shares
	. Unvested Shares may not be sold, transferred, pledged, or
	otherwise disposed of, except that such Unvested Shares may be transferred to a trust established
	for the sole benefit of the Purchaser and/or his or her spouse, children or grandchildren. Any
	Unvested Shares that are transferred as provided herein remain subject to the terms and conditions
	of this Agreement.
	6. Adjustments Upon Changes in Capital Structure
	. In the event that the outstanding shares of
	Common Stock of the Company are hereafter increased or decreased or changed into or exchanged for a
	different number or kind of shares or other securities of the Company by reason of a
	recapitalization, stock split, combination of shares, reclassification, stock dividend, or other
	change in the capital structure of the Company, then Purchaser shall be entitled to new or
	additional or different shares of stock or securities, in order to preserve, as nearly as
	practical, but not to increase, the benefits of Purchaser under this Agreement, in accordance with
	the provisions of Section 4.2 of the Plan. Such new, additional or different shares shall be
	deemed Shares for purposes of this Agreement and subject to all of the terms and conditions
	hereof.
	7. Shares Free and Clear
	. All Shares purchased by the Company pursuant to this Agreement
	shall be delivered by Purchaser free and clear of all claims, liens and encumbrances of every
	nature (except the provisions of this Agreement and any conditions concerning the Shares relating
	to compliance with applicable federal or state securities laws), and the purchaser thereof shall
	acquire full and complete title and right to all of such Shares, free and clear of any claims,
	liens and encumbrances of every nature (again, except for the provisions of this Agreement and such
	securities laws).
	 
	Page 3 of 7
 
	 
	8. Limitation of Companys Liability for Nonissuance; Unpermitted Transfers
	.
	(a) 
	The Company agrees to use its reasonable best efforts to obtain from any applicable
	regulatory agency such authority or approval as may be required in order to issue and sell the
	Shares to Purchaser pursuant to this Agreement. The inability of the Company
	to obtain, from any such regulatory agency, authority or approval deemed by the Companys
	counsel to be necessary for the lawful issuance and sale of the Shares hereunder and under the Plan
	shall relieve the Company of any liability in respect of the nonissuance or sale of such Shares as
	to which such requisite authority or approval shall not have been obtained.
	(b) 
	The Company shall not be required to: (i) transfer on its books any Shares of the Company
	which shall have been sold or transferred in violation of any of the provisions set forth in this
	Agreement, or (ii) treat as owner of such Shares or to accord the right to vote as such owner or to
	pay dividends to any transferee to whom such Shares shall have been so transferred.
	9. Notices
	. Any notice, demand or request required or permitted to be given under this
	Agreement shall be in writing and shall be deemed given when delivered personally or three (3) days
	after being deposited in the United States mail, as certified or registered mail, with postage
	prepaid, (or by such other method as the Administrator may from time to time deem appropriate), and
	addressed, if to the Company, at its principal place of business, Attention: the Chief Financial
	Officer, and if to the Purchaser, at his or her most recent address as shown in the employment or
	stock records of the Company.
	10. Binding Obligations
	. All covenants and agreements herein contained by or on behalf of any
	of the parties hereto shall bind and inure to the benefit of the parties hereto and their permitted
	successors and assigns.
	11. Captions and Section Headings
	. Captions and section headings used herein are for
	convenience only, and are not part of this Agreement and shall not be used in construing it.
	12. Interpretation
	. All Shares are issued pursuant to the terms of the Plan, and shall in all
	respects be interpreted in accordance therewith. The Administrator shall interpret and construe
	this Agreement and the Plan, and any action, decision, interpretation or determination made in good
	faith by the Administrator shall be final and binding on the Company and the Purchaser. As used in
	this Agreement, the term Administrator shall refer to the committee of the Board of Directors of
	the Company appointed to administer the Plan, and if no such committee has been appointed, the term
	Administrator shall mean the Board of Directors.
	13. Entire Agreement
	. This Agreement and the Plan constitute the entire agreement between the
	parties with respect to the subject matter hereof and supersede all prior or contemporaneous
	written or oral agreements and understandings of the parties, either express or implied.
	14. Assignment
	. Purchaser shall have no right, without the prior written consent of the
	Company, to (i) sell, assign, mortgage, pledge or otherwise transfer any interest or right created
	hereby, or (ii) delegate his or her duties or obligations under this Agreement. This Agreement is
	made solely for the benefit of the parties hereto, and no other person, partnership, association or
	corporation shall acquire or have any right under or by virtue of this Agreement.
	 
	Page 4 of 7
 
	 
	15. Severability
	. Should any provision or portion of this Agreement be held to be
	unenforceable or invalid for any reason, the remaining provisions and portions of this Agreement
	shall be unaffected by such holding.
	16. Counterparts
	. This Agreement may be executed in one or more counterparts, all of which
	taken together shall constitute one agreement and any party hereto may execute this Agreement by
	signing any such counterpart. This Agreement shall be binding upon Purchaser and the Company at
	such time as the Agreement, in counterpart or otherwise, is executed by Purchaser and the Company.
	17. Market Stand-Off Agreement
	. Purchaser agrees in connection with any registration of the
	Companys securities that, upon the request of the Company or the underwriters managing any public
	offering of the Companys securities, Purchaser will not sell or otherwise dispose of any Shares
	acquired by Purchaser without the prior written consent of the Company or such underwriters, as the
	case may be, for a period of time (not to exceed 180 days) from the effective date of such
	registration as the Company or the underwriters may specify.
	18. Tax Elections
	. Purchaser understands that Purchaser (and not the Company) shall be
	responsible for the Purchasers own tax liability that may arise as a result of the acquisition of
	the Shares. Purchaser acknowledges that Purchaser has considered the advisability of all tax
	elections in connection with the purchase of the Shares, including the making of an election under
	Section 83(b) under the Internal Revenue Code of 1986, as amended (Code); Purchaser further
	acknowledges that the Company has no responsibility for the making of such Section 83(b) election.
	In the event Purchaser determines to make a Section 83(b) election, Purchaser agrees to timely
	provide a copy of the election to the Company as required under the Code.
	19. Attorneys Fees
	. If any party shall bring an action in law or equity against another to
	enforce or interpret any of the terms, covenants and provisions of this Agreement, the prevailing
	party in such action shall be entitled to recover reasonable attorneys fees and costs.
	 
	Page 5 of 7
 
	 
	IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above
	written.
|  |  |  |  |  |  |  |  |  | 
| THE COMPANY: |  | PURCHASER: |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| ONCOGENEX PHARMACEUTICALS, INC. |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	By:
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	Name:
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  | (Print Name) |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	Title:
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  | Address: |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
 
	 
	Page 6 of 7
 
	 
	CONSENT AND RATIFICATION OF SPOUSE
	The undersigned, the spouse of
	                    
	, a party to the attached Restricted
	Stock Purchase Agreement (the Agreement), dated as of
	                    
	, hereby
	consents to the execution of said Agreement by such party; and ratifies, approves, confirms and
	adopts said Agreement, and agrees to be bound by each and every term and condition thereof as if
	the undersigned had been a signatory to said Agreement, with respect to the Shares (as defined in
	the Agreement) made the subject of said Agreement in which the undersigned has an interest,
	including any community property interest therein.
	I also acknowledge that I have been advised to obtain independent counsel to represent my
	interests with respect to this Agreement but that I have declined to do so and I hereby expressly
	waive my right to such independent counsel.
|  |  |  |  |  |  |  |  |  | 
| 
	Date:
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  | (Signature) |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  | (Print Name) |  |  | 
 
	 
	Page 7 of 7